First Three-Parent Baby
In September 2016, news broke that a baby boy was born using mitochondrial replacement therapy—effectively having DNA from three people: mother, father, and a mitochondrial donor. #ThreeParentBaby went viral as the unprecedented fertility technique sparked debates about genetic modification ethics, “designer babies,” and where society should draw lines on reproductive technology.
Preventing Mitochondrial Disease
Mitochondrial replacement therapy treats severe inherited mitochondrial diseases causing blindness, heart failure, neurological problems, and early death. The technique replaces defective maternal mitochondria with healthy donor mitochondria while retaining parents’ nuclear DNA. The baby inherits 99.8% DNA from parents, with only 0.2% (37 genes) from the mitochondrial donor.
UK Approval & Ethical Debates
The UK became the first country to legalize the procedure in 2015, with the first UK-approved babies born in 2023. #ThreeParentBaby tracked intense ethical debates: Is this germline editing? Does the mitochondrial donor qualify as a genetic parent? Should societies prevent heritable genetic modifications, or is preventing disease a moral imperative? Religious groups, ethicists, and scientists offered competing perspectives.
Global Regulation Divergence
Different nations took varied approaches: UK authorized with strict oversight, US prohibited clinical use, several countries performed procedures in regulatory grey areas. The hashtag highlighted global inconsistency in regulating reproductive technologies. As techniques improved and success rates increased, discussions continued about appropriate governance of technologies creating humans with genetic material from three individuals.
Sources: